NIH NIBIB DEBUT Challenge 2026 (Historical Reference): Biomedical Design Prizes for Undergraduate Teams

NIH NIBIB DEBUT Challenge 2026 (Historical Reference): Biomedical Design Prizes for Undergraduate Teams

The 2026 Design by Biomedical Undergraduate Teams (DEBUT) Challenge was a national biomedical design competition led by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health. It invited undergraduate teams to develop devices, products, or other technologies addressing unmet health and clinical problems. The 2026 submission period is closed. The official NIH challenge page records the deadline as June 5, 2026, at 11:59 PM EDT, and the NIH Challenges index places the challenge under closed challenges. No later DEBUT application deadline is announced on the official NIH pages reviewed for this update, so this listing is intentionally preserved as a historical reference rather than presented as an open call.

This archive is useful for teams planning around a future announcement because it records what the completed cycle required. It is not an invitation to submit after the deadline. The program is a prize competition, not an NIH grant, fellowship, or general-purpose research award. Teams were expected to show a real clinical or health problem, explain the proposed design, document implementation, and provide evidence of a working prototype where one had been built.

Verified 2026 details

The NIH amount is the important figure when describing federal prize funding. It includes the three principal prizes, eight categorical prizes, and five honorable mentions. The full DEBUT partnership could offer up to $190,000 when the separate VentureWell prizes are included. VentureWell’s published prize categories were a $10,000 Venture Prize, a $5,000 Design Excellence Prize, and a $5,000 Rising Star Prize. Each winning team received one prize only, and VentureWell prizes were paid to the winning team’s university for allocation under the applicable faculty-advisor process.

What the 2026 challenge supported

DEBUT focused on practical biomedical innovation rather than a single disease area. The official challenge described examples such as diagnostics, therapeutics, and point-of-care devices. It also highlighted technologies for underserved populations or low-resource settings in the United States and U.S. territories, people with disabilities, healthy aging, women’s health, and conditions including cancer, HIV/AIDS, and diabetes. A team did not need to work in one of those named areas to compete for the general prizes, but the application could identify a relevant categorical prize and explain the connection in the clinical-need section.

The three principal NIBIB prizes were the Steven H. Krosnick First Prize at $20,000, Second Prize at $15,000, and Third Prize at $10,000. Eight additional NIBIB-supported categories each carried $15,000: HIV/AIDS; Healthcare Technologies for Low-Resource Settings; Technologies for Cancer Prevention, Diagnosis or Treatment; Rehabilitative and Assistive Technologies; Technologies to Empower Nurses in Community Settings; Kidney Technology Development; Technologies to Improve the Health of Women; and Technologies to Foster Healthy Aging. Five honorable mentions carried $1,000 each. All NIH prize winners, including honorable mentions and non-U.S. citizen members of winning teams, could take part in Phase 1 of the DEBUT Concept to Clinic: Commercialization-Innovation (dC3i) course. At NIBIB’s discretion, up to three teams completing Phase 1 could be offered Phase 2 training.

The judging criteria rewarded more than a clever concept. NIBIB evaluated the significance of the problem, the likely impact on users and clinical care, innovative design, and whether the entry implemented its design in a working prototype that produced targeted results. The published guidance emphasizes evidence such as test results, photographs, graphs, films, or other documentation. VentureWell’s additional criteria addressed market potential, economic feasibility, patentability, and commercialization potential. Those criteria made the competition especially relevant to capstone teams and student innovation groups that could connect user or clinician input to a built and tested design.

Eligibility rules for the completed cycle

For NIBIB prize eligibility, each student had to be an undergraduate enrolled full-time in an undergraduate curriculum at a U.S. college or university during at least one full semester, or one full quarter where applicable, of the 2025-2026 academic year. Students who could not meet the full-time requirement because of a disability or medical condition could request a special accommodation from the DEBUT manager. Senior biomedical engineering capstone teams were especially encouraged to enter, and multidisciplinary teams could include students from fields such as business, nursing, physical therapy, life sciences, and physical sciences.

Teams had to contain at least three and no more than eight students. A student could belong to only one team. At an institution with a biomedical engineering or bioengineering department, at least one team member had to major in one of those fields. That major requirement was waived for an institution without a formal biomedical engineering or bioengineering department. Inter-institutional collaborations were allowed and required a faculty advisor from each participating institution under the published guidelines.

Citizenship affected prize payment rather than basic team participation in a simple all-or-nothing way. For NIBIB prizes, a student had to be a U.S. citizen or permanent resident to receive monetary prize funds. Non-U.S. citizens or non-U.S. permanent residents studying in the United States could be members of a competing team, could be listed among winning team members, and could participate in the commercialization training, but they would not receive a monetary share of an NIBIB prize. The Team Captain had to be a U.S. citizen or permanent resident and was the team’s official correspondent.

Participants had to be at least 13 years old. Any team member younger than 18 required a completed parental consent form. Other exclusions covered federal entities and federal employees acting within the scope of employment, judges and people involved in producing or distributing the challenge, and immediate family members of those restricted parties. The entry had to be conceived, designed, and implemented by the student team without significant contribution from other individuals. It also could not infringe third-party rights. Prior DEBUT entries could be resubmitted by the same team only if they had not previously won a prize; prior winners could return with a different entry.

What the application required

The 2026 process allowed one entry per student team. The Team Captain registered through the VentureWell submission portal and submitted the entry on behalf of the team. During registration, the team could choose consideration for NIBIB prizes, VentureWell prizes, or both. That choice mattered because the two sponsors had overlapping but distinct eligibility and judging rules.

The required submission was a single PDF containing four components:

1. The NIBIB DEBUT Challenge Certification Form, with the project title, team-member information, citizenship or permanent-residency indication, dates, and signatures for every team member.

2. A Project Narrative no longer than six pages, using Arial at a minimum size of 11 points. The required sections were an abstract; a description of the clinical need or problem with background and current methods; a project objective statement and explanation of innovative aspects; design documentation; prototype documentation with evidence of function and evaluation where applicable; and a link to a three-minute project video. The six-page limit included graphics but excluded the certification form, parental consent form, and references.

3. A sponsor letter on department letterhead from a faculty member in biomedical engineering, bioengineering, or a similar department. The letter had to verify that the named students achieved the entry, that each member was enrolled full-time during the relevant academic year, and what the advisor or other outside contributors did. At institutions without a formal biomedical engineering or bioengineering department, an appropriate faculty member familiar with the team and project could provide the letter.

4. A completed parental consent form for every team member under 18.

The video link was not optional. It had to describe the background and problem, explain the conceptual design and how it addressed the problem, and show a functional prototype where applicable. Video content longer than three minutes would not be considered. Teams could also submit a separate PDF with up to three support letters, up to three background articles or reports, and up to three video or website links, but the judges were expected to focus mainly on the required package.

How a future team should use this archive

Because the 2026 round has ended and no subsequent DEBUT deadline is listed on the official NIH challenge pages reviewed here, teams should not reuse the archived date as a future submission target. A future cycle would need its own announcement and may change the academic-year requirement, prize categories, portal, or forms. The most reliable preparation is to monitor the NIH Challenges and Prize Competitions index, the NIBIB DEBUT materials, and VentureWell’s DEBUT guidelines for a new notice.

For planning purposes, the completed cycle shows the work that should be ready before a new call opens. Start by choosing a specific health or clinical problem and collecting evidence from intended users or clinicians. Define exactly what the student team built if the work is part of a larger class, laboratory, or advisor-led project. Build and test a prototype early enough to collect meaningful results rather than relying on concept drawings. Then prepare a short narrative that lets a reviewer understand the need, design choices, test method, and limitations without requiring specialist knowledge.

Administrative preparation is equally important. Confirm team size and student status, appoint an eligible Team Captain, obtain faculty verification, check intellectual-property rights for every outside component, and gather signatures before the portal closes. If a future application seeks a categorical prize, identify that category in the clinical-need discussion and address its stated population or care problem directly. Keep the three-minute video focused on the problem, design, and demonstrated operation. These steps reflect the verified 2026 requirements, but they should be rechecked against any later official announcement.

Official sources

• NIH 2026 DEBUT Challenge announcement
• NIH Challenges and Prize Competitions index
• VentureWell DEBUT guidelines
• NIMHD DEBUT Challenge information